143 related articles for article (PubMed ID: 12488664)
1. Multicenter, randomized, double blind clinical trial of short course versus standard course oral ciprofloxacin for Shigella dysenteriae type 1 dysentery in children.
Zimbabwe, Bangladesh, South Africa (Zimbasa) Dysentery Study Group
Pediatr Infect Dis J; 2002 Dec; 21(12):1136-41. PubMed ID: 12488664
[TBL] [Abstract][Full Text] [Related]
2. [Short-term ciprofloxacin treatment of bacillary dysentery due to Shigella dysenteriae type 1 in Rwandan refugees].
Soares JL; Arendt V; Coue JC; Milleliri JM; Philips B; Regis R; Mérouze F; Rey JL
Med Trop (Mars); 1994; 54(4):319-23. PubMed ID: 7746123
[TBL] [Abstract][Full Text] [Related]
3. Treatment of shigellosis: III. Comparison of one- or two-dose ciprofloxacin with standard 5-day therapy. A randomized, blinded trial.
Bennish ML; Salam MA; Khan WA; Khan AM
Ann Intern Med; 1992 Nov; 117(9):727-34. PubMed ID: 1416574
[TBL] [Abstract][Full Text] [Related]
4. Randomised comparison of ciprofloxacin suspension and pivmecillinam for childhood shigellosis.
Salam MA; Dhar U; Khan WA; Bennish ML
Lancet; 1998 Aug; 352(9127):522-7. PubMed ID: 9716056
[TBL] [Abstract][Full Text] [Related]
5. Treatment of shigellosis: V. Comparison of azithromycin and ciprofloxacin. A double-blind, randomized, controlled trial.
Khan WA; Seas C; Dhar U; Salam MA; Bennish ML
Ann Intern Med; 1997 May; 126(9):697-703. PubMed ID: 9139555
[TBL] [Abstract][Full Text] [Related]
6. Haemolytic uraemic syndrome due to ciprofloxacin-resistant Shigella dysenteriae serotype 1.
Taneja N; Lyngdoh VW; Sharma M
J Med Microbiol; 2005 Oct; 54(Pt 10):997-998. PubMed ID: 16157557
[TBL] [Abstract][Full Text] [Related]
7. The anti-shigellosis activity of the methanol extract of Picralima nitida on Shigella dysenteriae type I induced diarrhoea in rats.
Kouitcheu LB; Tamesse JL; Kouam J
BMC Complement Altern Med; 2013 Aug; 13():211. PubMed ID: 23957940
[TBL] [Abstract][Full Text] [Related]
8. Ciprofloxacin and loperamide in the treatment of bacillary dysentery.
Murphy GS; Bodhidatta L; Echeverria P; Tansuphaswadikul S; Hoge CW; Imlarp S; Tamura K
Ann Intern Med; 1993 Apr; 118(8):582-6. PubMed ID: 8452323
[TBL] [Abstract][Full Text] [Related]
9. Epidemic dysentery caused by Shigella dysenteriae type 1: a sentinel site surveillance of antimicrobial resistance patterns in Burundi.
Engels D; Madaras T; Nyandwi S; Murray J
Bull World Health Organ; 1995; 73(6):787-91. PubMed ID: 8907772
[TBL] [Abstract][Full Text] [Related]
10. [Ciprofloxacin in the treatment of dysentery caused by type 1 Shigella dysenteriae during an epidemic in Rwandan refugees in Goma in 1994].
Laureillard D; Paquet C; Malvy D
Sante; 1998; 8(4):303-5. PubMed ID: 9794043
[TBL] [Abstract][Full Text] [Related]
11. Re-emergence of multi-drug resistant Shigella dysenteriae with added resistance to ciprofloxacin in north India & their plasmid profiles.
Taneja N; Lyngdoh V; Vermani A; Mohan B; Rao P; Singh M; Dogra A; Singh MP; Sharma M
Indian J Med Res; 2005 Oct; 122(4):348-54. PubMed ID: 16394329
[TBL] [Abstract][Full Text] [Related]
12. Treatment of shigellosis with cefixime: two days vs. five days.
Martin JM; Pitetti R; Maffei F; Tritt J; Smail K; Wald ER
Pediatr Infect Dis J; 2000 Jun; 19(6):522-6. PubMed ID: 10877166
[TBL] [Abstract][Full Text] [Related]
13. Multiple drug-resistant Shigella dysenteriae type 1 in Rajbari district, Bangladesh.
Jahan Y; Hossain A
J Diarrhoeal Dis Res; 1997 Mar; 15(1):17-20. PubMed ID: 9308296
[TBL] [Abstract][Full Text] [Related]
14. Hyperimmune bovine colostrum in the treatment of shigellosis in children: a double-blind, randomized, controlled trial.
Ashraf H; Mahalanabis D; Mitra AK; Tzipori S; Fuchs GJ
Acta Paediatr; 2001 Dec; 90(12):1373-8. PubMed ID: 11853331
[TBL] [Abstract][Full Text] [Related]
15. Low risk of hemolytic uremic syndrome after early effective antimicrobial therapy for Shigella dysenteriae type 1 infection in Bangladesh.
Bennish ML; Khan WA; Begum M; Bridges EA; Ahmed S; Saha D; Salam MA; Acheson D; Ryan ET
Clin Infect Dis; 2006 Feb; 42(3):356-62. PubMed ID: 16392080
[TBL] [Abstract][Full Text] [Related]
16. Oral ciprofloxacin vs. intramuscular ceftriaxone as empiric treatment of acute invasive diarrhea in children.
Leibovitz E; Janco J; Piglansky L; Press J; Yagupsky P; Reinhart H; Yaniv I; Dagan R
Pediatr Infect Dis J; 2000 Nov; 19(11):1060-7. PubMed ID: 11099086
[TBL] [Abstract][Full Text] [Related]
17. Randomized trial of high- and low-dose ampicillin therapy for treatment of severe dysentery due to Shigella dysenteriae type 1.
Gilman RH; Koster F; Islam S; McLaughlin J; Rahaman MM
Antimicrob Agents Chemother; 1980 Mar; 17(3):402-5. PubMed ID: 6999981
[TBL] [Abstract][Full Text] [Related]
18. Activities of aqueous extracts of Mallotus oppositifolium on Shigella dysenteriae A1-induced diarrhoea in rats.
Kamgang R; Vidal Pouokam Kamgne E; Fonkoua MC; Penlap N Beng V; Biwolé Sida M
Clin Exp Pharmacol Physiol; 2006; 33(1-2):89-94. PubMed ID: 16445705
[TBL] [Abstract][Full Text] [Related]
19. Introduction and spread of multi-resistant Shigella dysenteriae I in Thailand.
Taylor DN; Bodhidatta L; Brown JE; Echeverria P; Kunanusont C; Naigowit P; Hanchalay S; Chatkaeomorakot A; Lindberg AA
Am J Trop Med Hyg; 1989 Jan; 40(1):77-85. PubMed ID: 2644859
[TBL] [Abstract][Full Text] [Related]
20. Distribution and antibiotic susceptibility of Shigella isolates in Bangui, Central African Republic.
Bercion R; Njuimo SP; Boudjeka PM; Manirakiza A
Trop Med Int Health; 2008 Apr; 13(4):468-71. PubMed ID: 18282240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
